Daniel C. Beachler, PhD, MHS

Staff VP
Carelon Research
Wilmington, Delaware, United States

Disclosure information not submitted.

Presentation(s):

• SC-05 - Using pharmacoepidemiology database resources to address drug safety research

  Friday, August 22, 2025
  9:00 AM - 12:30 PM ET

• 2C-06 - Analyzing Incidence of Adverse Events Commonly Assessed in Vaccine Safety Studies in Medicaid versus Commercially-Insured Populations in Carelon Research’s OMOP Data

  Sunday, August 24, 2025
  4:45 PM - 5:00 PM ET

• 2E - Methods mixer

  Sunday, August 24, 2025
  3:30 PM - 5:00 PM ET

• 4C-06 - Evolution of Drug Initiation Patterns and Clinical Characteristics of New Users of Dapagliflozin in the United States up to 10 Years After Approval to Treat Type 2 Diabetes

  Monday, August 25, 2025
  5:30 PM - 5:45 PM ET